This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.

2026 data Public-data reference. official source

Beth Israel Deaconess Medical Center

Open-data reference.

Liver Transplant · Massachusetts

Data Insight

Beth Israel Deaconess Medical Center's liver transplant program is one of 124 liver programs tracked by the Scientific Registry of Transplant Recipients (SRTR) in the November 2025 Program-Specific Report cohort. The center is located in Massachusetts and reports under SRTR center code MABI. These program-level statistics are risk-adjusted for recipient and donor characteristics, which means survival estimates account for factors such as age, diagnosis, and prior medical history rather than comparing raw outcomes.

For the current cohort, this program reports a 1-year graft survival rate of 93.5% and a 3-year rate of 84.1%, compared with a national risk-adjusted benchmark of 92.4% at 1 year. The program performed approximately 291 liver transplants during the reporting window. An estimated 16 candidates sit on this program's waiting list, though time-to-transplant depends heavily on OPTN allocation rules for liver, blood type, medical urgency, and geography.

Among the 124 liver transplant programs reporting to SRTR for this cohort, Beth Israel Deaconess Medical Center ranks #48 by 1-year graft survival, placing the center 1.1 percentage points above the national benchmark. SRTR releases updated Program-Specific Reports approximately twice yearly (typically May and November), and each release incorporates a rolling cohort that may lag by 6-18 months because survival outcomes require follow-up. This page reflects the November 2025 release and is not medical advice — discuss these figures with a qualified transplant team in the context of your individual health status.

93.5%
1-Year Survival
+1.1% vs national
84.1%
3-Year Survival
291
Transplants/yr
16
On Waitlist

National Ranking

By 1-year graft survival rate: #48 of 124 reporting centers

Center 1-yr: 93.5%
National avg 1-yr: 92.4%
Center 3-yr: 84.1%
National avg 3-yr: 86.0%

Other Liver Programs

Top-ranked peer programs by 1-year graft survival rate.

Frequently Asked Questions

What is the liver transplant survival rate at Beth Israel Deaconess Medical Center?

According to SRTR data from November 2025, Beth Israel Deaconess Medical Center reports a 1-year graft survival rate of 93.5% for liver transplants, compared to a national average of 92.4%. The 3-year survival rate is 84.1%. Survival rates are risk-adjusted estimates and may not predict individual outcomes.

How many liver transplants does Beth Israel Deaconess Medical Center perform?

Beth Israel Deaconess Medical Center performed approximately 291 liver transplants during the most recent SRTR reporting period. Higher transplant volume is often associated with greater center experience, though volume alone does not determine outcomes. The OPTN recommends considering multiple factors when evaluating a transplant center.

How long is the liver transplant waiting list at Beth Israel Deaconess Medical Center?

According to the latest SRTR data, approximately 16 patients are on the liver transplant waiting list at Beth Israel Deaconess Medical Center. Wait times depend on factors including blood type, medical urgency, body size, geographic region, and organ allocation policies set by OPTN/UNOS. Your transplant team can provide a personalized estimate.

How does Beth Israel Deaconess Medical Center rank nationally for liver transplants?

Beth Israel Deaconess Medical Center ranks #48 out of 124 reporting liver transplant centers nationally by 1-year graft survival rate. The center's rate is 1.1 percentage points above the national average. Rankings are based on SRTR risk-adjusted estimates and exclude centers with insufficient case volume for statistical reliability.

What should I consider before choosing Beth Israel Deaconess Medical Center for a liver transplant?

Beyond survival statistics, important factors include the center's experience with liver transplants, geographic proximity (which affects organ allocation timing through OPTN distribution policies), your insurance network, the multidisciplinary team's expertise, post-transplant follow-up logistics, and the availability of living donor programs if applicable. Discuss all options with your referring physician and the transplant team at Beth Israel Deaconess Medical Center.

Data Sources

  • SRTR Program-Specific Reports (November 2025 release) — program-level survival rates, transplant volume, and waitlist size for Beth Israel Deaconess Medical Center. srtr.org
  • OPTN liver allocation policy — organ-specific allocation rules referenced in this page's narrative. optn.transplant.hrsa.gov

About This Data

This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care.

Source: SRTR Program-Specific Reports, November 2025 SRTR Program-Specific Reports, November 2025 Rankings exclude centers with insufficient case volume for statistical reporting